Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Stem Neoplasms | 10 | 2020 | 190 | 1.490 |
Why?
|
| Glioma | 14 | 2024 | 3418 | 0.810 |
Why?
|
| Brain Neoplasms | 14 | 2024 | 8981 | 0.760 |
Why?
|
| Neurofibromatosis 1 | 1 | 2022 | 560 | 0.550 |
Why?
|
| Magnetic Resonance Imaging | 24 | 2024 | 36285 | 0.510 |
Why?
|
| Anorexia Nervosa | 3 | 2018 | 1361 | 0.430 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 754 | 0.400 |
Why?
|
| Bone Marrow | 6 | 2022 | 2909 | 0.290 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2024 | 3339 | 0.270 |
Why?
|
| Benzimidazoles | 2 | 2022 | 855 | 0.260 |
Why?
|
| Fluorodeoxyglucose F18 | 4 | 2017 | 2004 | 0.250 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 7 | 2022 | 2782 | 0.240 |
Why?
|
| Temporal Muscle | 1 | 2023 | 36 | 0.220 |
Why?
|
| Contrast Media | 2 | 2016 | 5298 | 0.220 |
Why?
|
| Growth Charts | 1 | 2023 | 60 | 0.220 |
Why?
|
| Child | 30 | 2024 | 79813 | 0.210 |
Why?
|
| Knee | 2 | 2017 | 276 | 0.200 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 8946 | 0.190 |
Why?
|
| Adolescent | 26 | 2024 | 87888 | 0.170 |
Why?
|
| Transposition of Great Vessels | 2 | 2014 | 590 | 0.170 |
Why?
|
| Perfusion Imaging | 1 | 2020 | 196 | 0.160 |
Why?
|
| Permeability | 2 | 2018 | 718 | 0.150 |
Why?
|
| Levonorgestrel | 1 | 2018 | 74 | 0.150 |
Why?
|
| Ethinyl Estradiol | 1 | 2018 | 114 | 0.150 |
Why?
|
| Dehydroepiandrosterone | 1 | 2018 | 257 | 0.140 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2018 | 275 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2020 | 11709 | 0.130 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2024 | 2053 | 0.130 |
Why?
|
| Bone Density | 3 | 2022 | 3533 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2017 | 3758 | 0.120 |
Why?
|
| Cerebellar Neoplasms | 1 | 2018 | 587 | 0.110 |
Why?
|
| Adiposity | 2 | 2022 | 1858 | 0.110 |
Why?
|
| Benchmarking | 1 | 2020 | 1042 | 0.110 |
Why?
|
| Retrospective Studies | 11 | 2024 | 80170 | 0.110 |
Why?
|
| Medulloblastoma | 1 | 2018 | 679 | 0.110 |
Why?
|
| Quinazolines | 3 | 2015 | 1360 | 0.110 |
Why?
|
| Child, Preschool | 14 | 2024 | 42058 | 0.110 |
Why?
|
| Radiopharmaceuticals | 2 | 2014 | 2634 | 0.110 |
Why?
|
| Administration, Oral | 2 | 2018 | 3993 | 0.100 |
Why?
|
| Female | 33 | 2024 | 390316 | 0.100 |
Why?
|
| Absorptiometry, Photon | 3 | 2022 | 1735 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2018 | 2020 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2015 | 9273 | 0.100 |
Why?
|
| Positron-Emission Tomography | 5 | 2017 | 6457 | 0.090 |
Why?
|
| Male | 33 | 2024 | 358742 | 0.090 |
Why?
|
| Water | 3 | 2022 | 1402 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2020 | 10112 | 0.090 |
Why?
|
| Humans | 43 | 2024 | 758381 | 0.090 |
Why?
|
| Research Report | 1 | 2013 | 367 | 0.090 |
Why?
|
| ROC Curve | 1 | 2018 | 3563 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 249 | 0.080 |
Why?
|
| Adipose Tissue | 2 | 2022 | 3299 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2022 | 2275 | 0.080 |
Why?
|
| Hypertensive Encephalopathy | 1 | 2009 | 10 | 0.080 |
Why?
|
| Ependymoma | 1 | 2012 | 320 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2011 | 843 | 0.080 |
Why?
|
| Weight-Bearing | 1 | 2011 | 517 | 0.080 |
Why?
|
| Phantoms, Imaging | 3 | 2014 | 2509 | 0.080 |
Why?
|
| Knee Prosthesis | 1 | 2011 | 394 | 0.080 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2009 | 50 | 0.080 |
Why?
|
| Diffusion | 4 | 2017 | 813 | 0.070 |
Why?
|
| Infant | 8 | 2024 | 36054 | 0.070 |
Why?
|
| Prognosis | 5 | 2020 | 29558 | 0.070 |
Why?
|
| Disease Progression | 3 | 2020 | 13468 | 0.070 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 916 | 0.070 |
Why?
|
| Disease-Free Survival | 5 | 2017 | 6821 | 0.070 |
Why?
|
| Algorithms | 3 | 2020 | 13959 | 0.070 |
Why?
|
| Brain Stem | 1 | 2010 | 857 | 0.060 |
Why?
|
| Camptothecin | 3 | 2013 | 588 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3561 | 0.060 |
Why?
|
| Lumbar Vertebrae | 2 | 2022 | 1868 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 14641 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12262 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2009 | 1431 | 0.060 |
Why?
|
| Cerebral Angiography | 1 | 2009 | 1275 | 0.050 |
Why?
|
| Infant Behavior | 1 | 2004 | 154 | 0.050 |
Why?
|
| Knee Joint | 1 | 2011 | 1664 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2007 | 1705 | 0.050 |
Why?
|
| Histones | 2 | 2023 | 2577 | 0.050 |
Why?
|
| Femur Head | 1 | 2003 | 297 | 0.050 |
Why?
|
| Thalidomide | 1 | 2006 | 884 | 0.050 |
Why?
|
| Brain | 6 | 2005 | 26951 | 0.040 |
Why?
|
| Water-Electrolyte Balance | 1 | 2001 | 325 | 0.040 |
Why?
|
| Fingers | 1 | 2003 | 506 | 0.040 |
Why?
|
| Image Enhancement | 3 | 2005 | 2880 | 0.040 |
Why?
|
| Molecular Biology | 1 | 2023 | 580 | 0.040 |
Why?
|
| Anisotropy | 2 | 2014 | 1278 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 5629 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2014 | 2387 | 0.040 |
Why?
|
| Pons | 1 | 2019 | 239 | 0.040 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 3603 | 0.040 |
Why?
|
| Quinolones | 2 | 2011 | 377 | 0.040 |
Why?
|
| Cognition | 1 | 2014 | 6955 | 0.030 |
Why?
|
| Brain Edema | 1 | 2001 | 603 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2006 | 2047 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2022 | 1153 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 1894 | 0.030 |
Why?
|
| Movement | 1 | 2003 | 1474 | 0.030 |
Why?
|
| Cerebellum | 1 | 2003 | 1497 | 0.030 |
Why?
|
| Motor Cortex | 1 | 2003 | 997 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9461 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 20052 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 390 | 0.030 |
Why?
|
| Ischemia | 1 | 2003 | 1863 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2004 | 2092 | 0.030 |
Why?
|
| Infant, Newborn | 5 | 2022 | 26182 | 0.030 |
Why?
|
| Moyamoya Disease | 1 | 1997 | 256 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 15225 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 769 | 0.030 |
Why?
|
| Ice | 1 | 2014 | 102 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 2 | 2009 | 2731 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 6493 | 0.030 |
Why?
|
| Combined Modality Therapy | 3 | 2011 | 8530 | 0.030 |
Why?
|
| Survival Rate | 3 | 2013 | 12721 | 0.030 |
Why?
|
| Young Adult | 5 | 2024 | 58808 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5199 | 0.030 |
Why?
|
| Child Development | 1 | 2004 | 2285 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2001 | 1541 | 0.020 |
Why?
|
| Goats | 1 | 2011 | 167 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 4106 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2006 | 3480 | 0.020 |
Why?
|
| Lipids | 1 | 2022 | 3326 | 0.020 |
Why?
|
| Age Factors | 3 | 2017 | 18357 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1705 | 0.020 |
Why?
|
| Radiography | 2 | 2011 | 6955 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 10747 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 1975 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8554 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2359 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2004 | 6570 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2010 | 627 | 0.020 |
Why?
|
| Osteolysis | 1 | 2010 | 274 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 544 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 2014 | 7023 | 0.020 |
Why?
|
| Mutation | 2 | 2023 | 29915 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2019 | 64379 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2012 | 1268 | 0.020 |
Why?
|
| Executive Function | 1 | 2014 | 1375 | 0.020 |
Why?
|
| Tibia | 1 | 2011 | 1065 | 0.020 |
Why?
|
| Time Factors | 3 | 2015 | 39873 | 0.020 |
Why?
|
| Femur | 1 | 2011 | 1302 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2005 | 361 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2010 | 952 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2011 | 2896 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 2004 | 369 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2010 | 1504 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2013 | 22031 | 0.010 |
Why?
|
| Adult | 9 | 2014 | 219916 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2007 | 791 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 7980 | 0.010 |
Why?
|
| Infant Care | 1 | 2004 | 180 | 0.010 |
Why?
|
| Intensive Care, Neonatal | 1 | 2004 | 197 | 0.010 |
Why?
|
| Epiphyses | 1 | 2003 | 190 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2006 | 2640 | 0.010 |
Why?
|
| Internal Capsule | 1 | 2001 | 138 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1570 | 0.010 |
Why?
|
| Boston | 1 | 2013 | 9304 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 12870 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4048 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15785 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2010 | 8297 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11070 | 0.010 |
Why?
|
| HIV Infections | 1 | 2004 | 17275 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 3425 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2004 | 1489 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 12440 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 41252 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6233 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2020 | 54136 | 0.010 |
Why?
|
| Choline | 1 | 1997 | 513 | 0.010 |
Why?
|
| Research Design | 1 | 2011 | 6154 | 0.010 |
Why?
|
| Creatine | 1 | 1997 | 426 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1997 | 576 | 0.010 |
Why?
|
| Learning | 1 | 2004 | 1739 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 1997 | 823 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 4919 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9160 | 0.010 |
Why?
|
| Swine | 1 | 2003 | 5892 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 1066 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39060 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2007 | 3417 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2004 | 6187 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 13591 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1997 | 4159 | 0.000 |
Why?
|
| Animals | 2 | 2011 | 167777 | 0.000 |
Why?
|
| Risk Factors | 1 | 2013 | 73806 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 5759 | 0.000 |
Why?
|
| United States | 1 | 2007 | 72140 | 0.000 |
Why?
|
Concepts
(188)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(58)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_